Cardiac mass many years after heart transplantation-a case report

Lucia Dallapellegrina1,2, Edoardo Sciatti3, Enrico Vizzardi1,2

  • 1Cardiology Unit, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Brescia, Italy.

Insights

A rare case of late thrombus formation occurred in the neo-atrium after bi-atrial heart transplantation. This finding is unusual given the absence of atrial arrhythmia and prothrombotic medication use.

Area of Science:

  • Cardiology
  • Transplantation Surgery

Background:

  • The bi-atrial surgical technique for heart transplantation can lead to postoperative complications.
  • These include atrial dysfunction, sinus node issues, valvular problems, and atrial enlargement, increasing arrhythmia and thrombus risk.

Observation:

  • This report details an unusual case of very late thrombus formation.
  • The thrombus developed in the neo-atrium of a heart transplant recipient who underwent the bi-atrial technique.

Findings:

  • The patient had no history of atrial arrhythmia.
  • The patient had not taken any prothrombotic medications, making the thrombus formation noteworthy.

Implications:

  • This case highlights the potential for late complications even in the absence of typical risk factors.
  • Further research may be needed to understand the mechanisms of late thrombus formation in bi-atrial heart transplant recipients.

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...